RECURRENT ENDOMETRIAL CANCER
Clinical trials for RECURRENT ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted trial for black Women's cancer halted after just 4 patients
Disease control TerminatedThis study tested whether combining two existing cancer drugs (lenvatinib and pembrolizumab) could help control recurrent endometrial cancer specifically in Black patients. The trial was designed to address a lack of data in this population but was terminated early after enrollin…
Matched conditions: RECURRENT ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Targeted pill tested against hard-to-treat cancers
Disease control TerminatedThis study tested an oral medication called ART0380 for people with advanced or metastatic solid tumors that have specific weaknesses in their DNA repair system. It aimed to see if the drug could shrink tumors and was safe. The trial was designed for 36 participants, including th…
Matched conditions: RECURRENT ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Artios Pharma Ltd • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC